Consuming Coffee Linked to Lower Risk of Detrimental Liver Disease

Share this:

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings are being presented at the Digestive Disease Week 2013 conference in Orlando, Fla. PSC is an inflammatory disease of the bile ducts that results in inflammation and subsequent fibrosis that can lead to cirrhosis of the liver, liver failure and biliary cancer. Mayo Clinic gastroenterologist and study author Craig Lammert, M.D., says,“We’re always looking for ways to mitigate risk, and our first-time finding points to a novel environmental factor that also might help us to determine the cause of this and other devastating autoimmune diseases.”

Read EMBARGOED news release: Lammert Coffee PSC

Sound bites with Dr. Lammert are in the downloads

Expert title for broadcast cg: Craig Lammert, M.D., Mayo Clinic Gastroenterologist

Related Articles

Cancer

Mayo Clinic Minute: Stomach cancer in younger people

Research

Discovery reveals how to prevent organ damage in pancreatitis

Gastroenterology

‘I was in good hands’: Emergency surgery saves woman with rare pancreatic aneurysm